The relationship between hyperlipidemia and insulin resistance is bi-directional as a key physiological function of insulin is to restrain lipolysis and to promote fat storage in adipose tissue in the postprandial state [70], making it likely that insulin resistance contributes to hyperlipidemia in cancer. The gene discussed is INS; the disease is cancer.